跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SINGULAIR montelukast 4 mg (as sodium) oral granules sachet - TGA Drug Approval Details
Approvals
/
TGA
/
SINGULAIR montelukast 4 mg (as sodium) oral granules sachet
Approved
STANDARD
SINGULAIR montelukast 4 mg (as sodium) oral granules sachet
ORGANON PHARMA PTY LTD
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9cd94eca14faa44c
Company
ORGANON PHARMA PTY LTD
Type
Standard
Approval Details
Approval Id
9cd94eca14faa44c
Product Name
SINGULAIR montelukast 4 mg (as sodium) oral granules sachet
Artg Id
81450
Artg Name
SINGULAIR montelukast 4 mg (as sodium) oral granules sachet
Sponsor
ORGANON PHARMA PTY LTD
Company Detail Path
/organization/organon-pharma-pty-ltd
Artg Date
2002-11-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
https://medical-cdn.nocode.com/drug_tga/1446aacc27beae838a657b118af7d9ac.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9cd94eca14faa44c
Type
Standard
Back to TGA Approvals